Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
|
Re: Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
Oh, the study was published in the New England Journal of Medicine! This truly increases the credibility in many oncologist's mind.
I dare say that Phil's dream of seeing TDM1 approved is looming on the horizon. I can't wait until another treatment option is part of Standard of Care. |
All times are GMT -7. The time now is 04:16 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021